Daily Health Headlines

FDA OKs New Injectable Type 2 Diabetes Medication

👤by Robert Preidt 0 comments 🕔Friday, July 29th, 2016

THURSDAY, July 28, 2016 (HealthDay News) -- The injectable drug Adlyxin (lixisenatide) has been approved to treat adults with type 2 diabetes, the U.S. Food and Drug Administration says.

The once-daily injection is to be used along with diet and exercise to improve patients' blood sugar levels.

The FDA reviewed 10 clinical trials on the safety and effectiveness of Adlyxin. These studies included 5,400 people with type 2 diabetes. The drug was also specifically tested for heart issues in an additional 6,000 people at risk of heart disease, the FDA said Thursday in a news release.

The FDA concluded that Adlyxin helps normalize blood sugar levels. And it doesn't appear to increase the risk of heart problems.

Adlyxin is in a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. Other GLP-1 drugs include liraglutide (Victoza), exenatide (Byetta, Bydureon) and dulaglutide (Trulicity), according to the American Diabetes Association.

Adlyxin shouldn't be used to treat people with type 1 diabetes. It also shouldn't be used by anyone with increased ketones (a sign that the body isn't getting enough insulin) in their blood or urine, or extremely elevated ketones (diabetic ketoacidosis), the FDA said.

Common side effects of Adlyxin included nausea, vomiting, headache, diarrhea and dizziness, the findings showed. Low blood sugar (hypoglycemia) occurred in patients who took both Adlyxin and other diabetes drugs such as sulfonylureas and/or a long-acting (basal) insulin, the agency said.

Some people who took Adlyxin had severe hypersensitivity reactions, including serious allergic reactions (anaphylaxis), the agency said.

The FDA said it's requiring drug maker Sanofi-Aventis to conduct post-marketing studies of Adlyxin.

More than 29 million Americans have type 2 diabetes, the FDA noted. In the United States, type 2 diabetes accounts for over 90 percent of diabetes cases, the agency said. If left untreated, persistent high blood sugar levels can increase the risk of serious complications, such as heart disease, blindness, and nerve and kidney damage.

-- Robert Preidt

Article Credits / Source

Robert Preidt / HealthDay

Robert Preidt wrote this story for HealthDay. HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCE: U.S. Food and Drug Administration, news release, July 28, 2016

View More Articles From Robert Preidt 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Diabetes Articles

Low Blood Sugar Linked to Death Risk for Hospital Patients

Low Blood Sugar Linked to Death Risk for Hospital Patients0

THURSDAY, Nov. 17, 2016 (HealthDay News) -- Hospital patients with low blood sugar may be at increased risk for death, a new study from Israel suggests. The study included nearly 3,000 patients with low blood sugar (hypoglycemia). Nearly 32 ...

Can Protein, Probiotics Help With Blood Sugar Control?

Can Protein, Probiotics Help With Blood Sugar Control?0

THURSDAY, Nov. 17, 2016 (HealthDay News) -- Adding protein-rich or probiotic-laden foods to your diet may help control your blood sugar levels, according to a pair of new studies. Both proteins and probiotics appear to slow down digestion of ...

Health Tip: Creating an Insulin Routine

Health Tip: Creating an Insulin Routine0

(HealthDay News) -- If you take insulin, you'll need to create a comfortable routine to keep blood glucose under control. The American Diabetes Association explains: Type 1 diabetes typically needs at least two daily injections of two ...

Daily Can of Soda Boosts Odds for Prediabetes, Study Finds

Daily Can of Soda Boosts Odds for Prediabetes, Study Finds0

THURSDAY, Nov. 10, 2016 (HealthDay News) -- Drinking a can of sugary soda every day can dramatically heighten a person's risk of developing prediabetes, a "warning sign" condition that precedes full-blown type 2 diabetes, a new study reports. A ...

Nearly 6 in 10 Diabetics Skip Eye Exams, Study Finds

Nearly 6 in 10 Diabetics Skip Eye Exams, Study Finds0

THURSDAY, Nov. 10, 2016 (HealthDay News) -- Almost two-thirds of people with diabetes don't get annual eye exams, despite having an increased risk for serious eye disease and vision loss, researchers say. About one in 10 Americans has diabetes. ...

View More Diabetes Articles

0 Comments

Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!